These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended December 31, 2012
|
||
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from to
|
||
|
California
|
95-4298051
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
1251 Point View Street, Los Angeles, CA
|
90035
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
None
|
N/A
|
|
|
Title of each class
|
Name of each exchange on which registered
|
|
PART I
|
|||
|
ITEM 1:
|
BUSINESS
|
3
|
|
|
ITEM 1A
|
RISK FACTORS
|
8
|
|
|
ITEM 1B
|
UNRESOLVED STAFF COMMENTS
|
8
|
|
|
ITEM 2:
|
PROPERTIES
|
8
|
|
|
ITEM 3:
|
LEGAL PROCEEDINGS
|
9
|
|
|
ITEM 4:
|
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
|
|
|
PART II
|
|||
|
ITEM 5:
|
MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND PURCHASES OF EQUITY SECURITIES
|
9
|
|
|
ITEM 6:
|
SELECTED FINANCIAL DATA
|
10
|
|
|
ITEM 7:
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATION
|
10
|
|
|
ITEM 8:
|
FINANCIAL STATEMENTS
|
14
|
|
|
ITEM 9:
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
25
|
|
|
ITEM 9A(T):
|
CONTROLS AND PROCEDURES
|
25
|
|
|
ITEM 9B:
|
OTHER INFORMATION
|
26
|
|
|
PART III
|
|||
|
ITEM 10:
|
DIRECTORS, EXECUTIVE OFFICERS,
AND CORPORATE GOVERNANCE
|
27
|
|
|
ITEM 11:
|
EXECUTIVE COMPENSATION
|
28
|
|
|
ITEM 12:
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
29
|
|
|
ITEM 13:
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
, AND
DIRECTOR INDEPENDENCE
|
29
|
|
|
ITEM 14:
|
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
30
|
|
|
PART IV
|
|||
|
ITEM 15:
|
EXHIBITS
|
30
|
|
|
SIGNATURES
|
31
|
||
|
|
•
|
The worldwide economic situation;
|
|
|
•
|
Any change in interest rates or inflation;
|
|
|
•
|
The willingness and ability of third parties to honor their contractual commitments;
|
|
|
•
|
The Company’s ability to raise additional capital, as it may be affected by current conditions in the stock market and competition for risk capital;
|
|
|
•
|
The Company’s capital costs, as they may be affected by delays or cost overruns;
|
|
|
•
|
The Company’s costs of production;
|
|
|
•
|
Environmental and other regulations, as the same presently exist or may later be amended;
|
|
|
•
|
The Company’s ability to identify, finance and integrate any future acquisitions; and
|
|
|
•
|
The volatility of the Company’s stock price.
|
|
·
|
Potential for growth, indicated by new technology, anticipated market expansion or new products;
|
|
·
|
Competitive position as compared to other firms engaged in similar activities;
|
|
·
|
Strength of management;
|
|
·
|
Capital requirements and anticipated availability of required funds from future operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources; and
|
|
·
|
Other relevant factors.
|
|
Year Ending
|
High
|
Low
|
||||||
|
December 31, 2012
|
||||||||
|
First Quarter
|
$ | 0.01 | $ | 0.01 | ||||
|
Second Quarter
|
$ | 0.05 | $ | 0.01 | ||||
|
Third Quarter
|
$ | 0.02 | $ | 0.01 | ||||
|
Fourth Quarter
|
$ | 0.03 | $ | 0.02 | ||||
|
December 31, 2011
|
||||||||
|
First Quarter
|
$ | 0.010 | $ | 0.035 | ||||
|
Second Quarter
|
$ | 0.090 | $ | 0.030 | ||||
|
Third Quarter
|
$ | 0.0438 | $ | 0.020 | ||||
|
Fourth Quarter
|
$ | 0.0438 | $ | 0.012 | ||||
|
Index to Financial Statements:
|
|
|
Report of Independent Registered Public Accounting Firm for Fiscal Year Ended 2011 and 2010
|
15 |
|
Balance Sheets as of December 31,
2012 and 2011
|
16 |
|
Statements of Operations for the years ended December 31, 2012 and
2011, and
for the Development Period from October 11, 2006 to December 31, 2012
|
17 |
|
Statement of Changes in Stockholders’ (Deficit) for the
Development
Period from
October 11, 2006 to December 31, 2012
|
18 |
|
Statements of Cash Flows for the years ended December 31, 2012 and
2011, and
for the Development Period from October 11, 2006 to December 31, 2012
|
19 |
|
Notes to Financial Statements
|
20 |
|
/s/ Schumacher & Associates, Inc.
|
|
|
April 16, 2012
|
|
|
Denver, Colorado
|
|
|
December 31, 2012
|
December 31, 2011
|
|||||||
|
(Unaudited)
|
(Audited) | |||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Total current assets
|
$ | - | $ | - | ||||
|
LIABILITIES AND STOCKHOLDERS' (DEFICIT)
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 9,521 | $ | 8,305 | ||||
|
Accrued expenses
|
1,500 | 1,600 | ||||||
|
Advances payable - officer
|
6,934 | 6,934 | ||||||
|
Notes payable - stockholders
|
182,897 | 166,874 | ||||||
|
Accrued interest - stockholders
|
59,305 | 45,146 | ||||||
|
Total current liabilities
|
260,157 | 228,859 | ||||||
|
Commitments and contingencies (Notes 1, 2, 3, and 5)
|
||||||||
|
Stockholders' (deficit):
|
||||||||
|
Preferred stock - no par value, authorized 1,000,000 shares:
|
||||||||
|
No shares issued or outstanding
|
- | - | ||||||
|
Common stock - no par value, 100,000,000 shares authorized:
|
||||||||
|
14,425,903 shares issued and outstanding
|
6,903,766 | 6,903,766 | ||||||
|
Additional paid-in capital
|
230,000 | 230,000 | ||||||
|
Accumulated deficit through October 11, 2006
|
(7,302,235 | ) | (7,302,235 | ) | ||||
|
(Accumulated deficit) during development stage
|
(91,688 | ) | (60,390 | ) | ||||
|
Total stockholders' (deficit)
|
(260,157 | ) | (228,859 | ) | ||||
|
Total liabilities and stockholders' (deficit)
|
$ | 0.00 | $ | 0.00 | ||||
|
Development Period
|
||||||||||||
|
October 11, 2006
|
||||||||||||
|
2012
|
2011
|
to December 31, 2012
|
||||||||||
| (Unaudited) | (Audited) | (Unaudited) | ||||||||||
|
Revenues
|
$ | - | $ | - | $ | - | ||||||
|
Expenses:
|
||||||||||||
|
General and administrative:
|
||||||||||||
|
Financing costs
|
- | - | 2,917 | |||||||||
|
Consulting fees
|
- | - | 8,029 | |||||||||
|
Accounting and legal
|
10,385 | 9,648 | 120,974 | |||||||||
|
Investor relations
|
5,954 | 2,958 | 32,056 | |||||||||
|
Total expenses
|
16,339 | 12,606 | 163,976 | |||||||||
|
Operating (loss)
|
(16,339 | ) | (12,606 | ) | (163,976 | ) | ||||||
|
Other income (expense):
|
||||||||||||
|
Gain from litigation settlement
|
- | - | 137,310 | |||||||||
|
Interest (expense)
|
(14,160 | ) | (12,837 | ) | (59,306 | ) | ||||||
| (14,160 | ) | (12,837 | ) | 78,004 | ||||||||
|
Income (loss) before income taxes
|
(30,499 | ) | (25,443 | ) | (85,971 | ) | ||||||
|
Provision for income taxes
|
800 | 800 | 5,718 | |||||||||
|
Net income (loss)
|
$ | (31,299 | ) | $ | (26,243 | ) | $ | (91,689 | ) | |||
|
Net (loss) per common share:
|
||||||||||||
|
Basic and Diluted
|
$ |
Nil
|
$ | Nil |
|
|||||||
|
Weighted average shares outstanding:
|
||||||||||||
|
Basic and Diluted
|
14,425,903 | 14,425,903 | ||||||||||
|
(Accumulated
|
||||||||||||||||||||||||
|
Accumulated
|
Deficit)
|
|||||||||||||||||||||||
|
Additional
|
Deficit
|
During the
|
Total
|
|||||||||||||||||||||
|
Common Stock
|
Paid - in
|
through
|
Development
|
Stockholders'
|
||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
October 11, 2006
|
Stage
|
(Deficit)
|
|||||||||||||||||||
|
Balance, October 11, 2006
|
3,479,916 | $ | 6,892,820 | $ | 230,000 | $ | (7,302,235 | ) | $ | - | $ | (179,415 | ) | |||||||||||
|
Net (loss)
|
- | - | - | - | (26,440 | ) | (26,440 | ) | ||||||||||||||||
|
Balance, December 31, 2006
|
3,479,916 | 6,892,820 | 230,000 | (7,302,235 | ) | (26,440 | ) | (205,855 | ) | |||||||||||||||
|
Shares issued for loan fees at
|
||||||||||||||||||||||||
|
$0.001 per share, July 2, 2007
|
945,987 | 946 | - | - | - | 946 | ||||||||||||||||||
|
Shares issued for loan fees at
|
||||||||||||||||||||||||
|
$0.001 per share, November 14, 2007
|
10,000,000 | 10,000 | - | - | - | 10,000 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 91,889 | 91,889 | ||||||||||||||||||
|
Balance, December 31, 2007
|
14,425,903 | 6,903,766 | 230,000 | (7,302,235 | ) | 65,449 | (103,020 | ) | ||||||||||||||||
|
Net (loss)
|
- | - | - | - | (36,277 | ) | (36,277 | ) | ||||||||||||||||
|
Balance, December 31, 2008
|
14,425,903 | 6,903,766 | 230,000 | (7,302,235 | ) | 29,172 | (139,297 | ) | ||||||||||||||||
|
Net (loss)
|
- | - | - | - | (29,466 | ) | (29,466 | ) | ||||||||||||||||
|
Balance, December 31, 2009
|
14,425,903 | 6,903,766 | 230,000 | (7,302,235 | ) | (294 | ) | (168,763 | ) | |||||||||||||||
|
Net (loss)
|
- | - | - | - | (33,853 | ) | (33,853 | ) | ||||||||||||||||
|
Balance, December 31, 2010
|
14,425,903 | $ | 6,903,766 | $ | 230,000 | $ | (7,302,235 | ) | $ | (34,147 | ) | $ | (202,616 | ) | ||||||||||
|
Net (loss)
|
- | - | - | - | (26,243 | ) | (26,243 | ) | ||||||||||||||||
|
Balance, December 31, 2011
|
14,425,903 | $ | 6,903,766 | $ | 230,000 | $ | (7,302,235 | ) | $ | (60,390 | ) | $ | (228,859 | ) | ||||||||||
|
Net (loss)
|
- | - | - | - | (31,298 | ) | (31,298 | ) | ||||||||||||||||
|
Balance, December 31, 2012 (Unaudited)
|
14,425,903 | $ | 6,903,766 | $ | 230,000 | $ | (7,302,235 | ) | $ | (91,688 | ) | $ | (260,157 | ) | ||||||||||
|
Development Period
|
||||||||||||
|
October 11, 2006
|
||||||||||||
|
2012
|
2011
|
to December 31, 2012
|
||||||||||
| (Unaudited) | (Audited) | (Unaudited) | ||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income (loss)
|
$ | (24,688 | ) | $ | (26,243 | ) | $ | (85,078 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash
|
||||||||||||
|
used by operating activities:
|
||||||||||||
|
Gain from litigation settlement
|
- | (137,310 | ) | |||||||||
|
Shares issued for loan fees and consulting fees
|
- | 10,946 | ||||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Accounts payable
|
(1,506 | ) | (2,588 | ) | (7,556 | ) | ||||||
|
Accrued expenses
|
(300 | ) | 800 | 1,300 | ||||||||
|
Judgement payable
|
(27,750 | ) | ||||||||||
|
Accrued interest
|
10,471 | 12,836 | 55,616 | |||||||||
|
Total adjustments
|
8,665 | 11,048 | (104,754 | ) | ||||||||
|
Net cash (used in) operating activities
|
(16,023 | ) | (15,195 | ) | (189,832 | ) | ||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Net cash (used in) investing activities
|
- | - | - | |||||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from notes payable - stockholders
|
16,023 | 15,195 | 182,898 | |||||||||
|
Advances from officer
|
6,934 | |||||||||||
|
Net cash provided by financing activities
|
16,023 | 15,195 | 189,832 | |||||||||
|
Net increase in cash and equivalents
|
- | - | - | |||||||||
|
Cash and equivalents at beginning of year
|
- | - | - | |||||||||
|
Cash and equivalents at end of year
|
$ | - | $ | - | $ | - | ||||||
|
Supplemental Cash Flow Information
|
||||||||||||
|
Interest paid
|
$ | - | $ | - | $ | - | ||||||
|
Income taxes paid
|
$ | - | $ | - | $ | 7,670 | ||||||
|
Period Ending
|
Estimated NOL Carry-forward
|
NOL Expires
|
Potential Tax Benefit from NOL
|
Valuation Allowance
|
Change in Valuation Allowance
|
Net Tax Benefit
|
|||||
|
December 31, 2012
|
$500,000
|
2032
|
$113,250
|
$(113,250)
|
$--
|
$--
|
|||||
|
December 31, 2011
|
$500,000
|
2031
|
$113,250
|
$(113,250)
|
$--
|
$--
|
|
Income tax benefit at statutory rate resulting from net operating
loss carryforward
|
(15.00 | %) | ||
|
State tax (benefit) net of federal benefit
|
(7.65 | %) | ||
|
Deferred income tax valuation allowance
|
22.65 | % | ||
|
Actual tax rate
|
0 | % |
|
Board
|
|||||||||
|
Name and
|
Position
|
||||||||
|
Municipality of Residence
|
Age
|
Positions With the Company
|
Held Since
|
||||||
|
Borivoje Vukadinovic Los Angeles, CA
|
51 |
President, Chief Executive Officer, Chief Financial Officer and Director
|
1991 | ||||||
|
Name and
Principal Position
|
Year
|
Salary
|
All
Other
Compensation
|
Total
|
|||||||||
|
Borivoje Vukadinovic
|
2012
|
$ | 0 | $ | 0 | $ | 0 | ||||||
|
Director, C.E.O., and C.F.O.
|
|||||||||||||
|
2011
|
$ | 0 | $ | 0 | $ | 0 | |||||||
|
Name
|
Fees Earned or
Paid in Cash
|
Stock
Awards
|
Option
Awards
|
All
Other
Compensation
|
Total
|
||||||||||||||||
|
Borivoje Vukadinovic
|
$ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | |||||||||||
|
Name and Address of
|
Shares Beneficially Owned
|
|
|
Beneficial Owner
|
Number
|
Percentage (%)
|
|
Borivoje Vukadinovic
(1)
|
5,945,987
|
41.1%
|
|
112 West 9
th
Street, Suite 518
|
||
|
Los Angeles, CA 90015
|
||
|
Gary Agron
|
5,945,987
|
41.1%
|
|
5445 DTC Parkway, Suite 520
|
||
|
Englewood, CO 80111
|
||
|
All officers and directors as a group
|
||
|
(2 persons)
|
11,891,974
|
82.2%
|
|
2012
|
2011
|
|||||||
|
Audit Fees
|
$ | 7,600 | $ | 8,900 | ||||
|
Audit Related Fees
|
0 | 0 | ||||||
|
Tax Fees
|
0 | 0 | ||||||
|
All Other Fees
|
0 | 0 | ||||||
|
Total Fees
|
$ | 7,600 | $ | 8,900 | ||||
|
31.1
|
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic .
|
|
32.1
|
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic.
|
|
RETROSPETTIVA, INC.
|
|||
|
/s/ Borivoje Vukadinovic
|
|||
|
Dated: April 1, 2013
|
By: Borivoje Vukadinovic, Director, Chief Executive Officer, and Chief Financial Officer
|
||
|
RETROSPETTIVA, INC.
|
|||
|
/s/ Borivoje Vukadinovic
|
|||
|
Dated: April 1, 2013
|
By: Borivoje Vukadinovic, Director, Chief Executive Officer, and Chief Financial Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|